Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Apica in connection with funding round
Mandate

Vinge has advised Apica in connection with funding round

September 05, 2017

Vinge has advised Apica in connection with a 12 MUSD funding round, with the goal of helping Apica expand its market presence in the U.S. and Europe outside of the Nordics.

Among others OXX, SEB Venture Capital, KTH Chalmers Capital and Industrifonden have participated in the round. Apica is a Swedish company providing internet based services conducting load testing and performance analysis of business critical web applications.

Vinge´s team consisted of Johan Larsson, Martin Cronsioe and Marith Welin-Berger.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025